Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Jan-Mar;21(1):70-74.
doi: 10.4103/aian.AIAN_373_17.

A Viral Polymyositis Masquerade: Life-Threatening Case of Juvenile Dermatomyositis Complicated by Systemic Capillary Leak Syndrome

Affiliations
Case Reports

A Viral Polymyositis Masquerade: Life-Threatening Case of Juvenile Dermatomyositis Complicated by Systemic Capillary Leak Syndrome

Bhaskara P Shelley et al. Ann Indian Acad Neurol. 2018 Jan-Mar.

Abstract

This is a case report of an 8-year-old boy who developed an atypical, rare subphenotype of autoimmune inflammatory acute juvenile dermatomyositis (JDM), initially masquerading as viral polymyositis (PM)-like presentation, that was complicated by a hitherto unreported fulminant, life-threatening pediatric systemic capillary leak syndrome (SCLS). We highlight the close differential between viral PM and JDM, the baffling clinical syndromic constellation of hypotension with hemoconcentration - a "shock"-like syndrome, hypoalbuminemia without albuminuria, and generalized edema with the atypical JDM presentation, and stress crucial need to implement early aggressive, multipronged immunomodulatory treatment along with intensive fluid resuscitation which saved the life, this patient from a stormy, and turbulent 4-week clinical illness. This is the first published case description in the current literature of the association of an aggressive subphenotype of JDM and life-threatening pediatric SCLS. This report opens the Pandora's Box to explore the genetic and pathomechanisms of both disorders.

Keywords: Aggressive subphenotype; Clarkson syndrome; capillary leak syndrome; generalized pitting edema; juvenile dermatomyositis; muscle weakness; myositis; subcutaneous edema; systemic capillary leak.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
(a) Preserved fascicular architecture (H and E, ×40); (b and c) perifascicular atrophy (black arrow) (H and E, ×200); (b) inset– normal endomyseal collagen (Masson Trichrome, ×200); (d) perimyseal perivascular lymphocytic infiltrate (black arrow) (H and E, ×200); (e) endomyseal perivascular lymphocytic infiltrate (black arrow) (H and E, ×200); (f) basophilic regenerating myofibre (black arrow) and myonecrosis (red arrow) (H and E, ×200)

Similar articles

Cited by

References

    1. Maugars YM, Berthelot JM, Abbas AA, Mussini JM, Nguyen JM, Prost AM, et al. Long-term prognosis of 69 patients with dermatomyositis or polymyositis. Clin Exp Rheumatol. 1996;14:263–74. - PubMed
    1. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality. Rheumatology (Oxford) 2002;41:22–6. - PubMed
    1. Marie I, Hachulla E, Hatron PY, Hellot MF, Levesque H, Devulder B, et al. Polymyositis and dermatomyositis: Short term and longterm outcome, and predictive factors of prognosis. J Rheumatol. 2001;28:2230–7. - PubMed
    1. Murthy JM. Drug treatment of polymyositis and dermatomyositis. Neurol India. 2010;58:3–5. - PubMed
    1. Hall VC, Keeling JH, Davis MD. Periorbital edema as the presenting sign of dermatomyositis. Int J Dermatol. 2003;42:466–7. - PubMed

Publication types